Publications
Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
András Incze | Zoltán Kaló | Jaime Espín
Éva Kiss | Sophia Kessabi | Louis P. Garrison
Frontiers in Pharmacology, April 2022
No International Reference Pricing for drugs in the US – good news for patients in the US and worldwide
András Incze
LinkedIn, September 2021
Jordan C. Rozum | Jorge Gómez Tejeda Zañudo | Xiao Gan | Dávid Deritei | Réka Albert Science Advances, June 2021
Lou Garrison, Andras Incze, Jaime Espin, and Zoltan Kalo
ISPOR, November 2020
U.S. vs. Rest of world–Who Is Shooting Whose Foot?
Lou Garrison, Jamie Espin, Zoltán Kalo, András Incze
ISPOR, May 2020
Shilling C, Incze A.
Business Development and Licensing Journal, 2017 July 25
Amoaku W, Bishop P, Foss A, Hoad G, Johnston R, Luthert P, Shilling C, Smith J.
March 2016.
Shilling C.
BioStars, January 2016
Incze A, Noehrenberg E.
EPP Montreux, June 4-5, 2014
Incze A.
EPP Montreux, June 5-6, 2013
Incze A.
World Biosimilar Conference, London, September 2012
Incze A.
3rd Annual Payer Experiences Conference, Berlin June 2011
Thompson D, Campbell J, Parekh H, Vincze G, Incze A, Navarro J, Weinstein C M.
ISPOR LATAM Conference, September 2009
Gabriela Tannus Branco de Araújo, Incze A.
ISPOR LATAM Conference Podium Presentation, September 2009